(Q73269119)

English

Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy

scientific article published on 01 October 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

Guillaume Cartron

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

C Linassier

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Barin

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Calais

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Letortorec

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J L Brémond

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Delain

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Petit

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M T Georget

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

N Raban

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L Benboubker

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Leloup

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Binet

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J P Lamagnère

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Colombat

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1289-1294

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukemia after therapy with alkylating agents for childhood cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

The association of specific "favorable" cytogenetic abnormalities with secondary leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable cytogenetic abnormalities in secondary leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary leukemias induced by topoisomerase-targeted drugs

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular uptake and tubulin binding properties of four Vinca alkaloids

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of New Primary Cancers After Adjuvant Tamoxifen Therapy and Radiotherapy for Early Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy-related acute promyelocytic leukemia: a report on 16 cases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of differe

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. EU Concerted Action 11q23 Workshop

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions of antitumor agents ametantrone∗∗Trade name for the salt of 1,4-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione (Fig. 1, I). Abbreviations: HAQ, ANT; NSC-287513. and mitoxantrone (novatrone)††Trade name for the sa

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitoxantrone-induced DNA damage in leukemia cells is enhanced by treatment with high-dose arabinosylcytosine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

A case of therapy-related acute myeloblastic leukemia with t(16;21)(q24;q22) after chemotherapy with DNA-topoisomerase II inhibitors, etoposide and mitoxantrone, and the alkylating agent, cyclophosphamide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplasia and acute myeloid leukaemia following adjuvant chemotherapy for breast cancer using mitoxantrone and methotrexate with or without mitomycin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Two different classes of therapy-related and de-novo acute myeloid leukemia?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008375016038

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008375016038

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11106118%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73269119&oldid=1756745105"